NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/12/2026
Back to search
Official data from USPTO
EPHARMIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EPHARMIX
ST13
US500000086634737Class
38, 42
Filing
86634737
Registration
4912606
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
06/02/2026
Trademark type
Word
Nice classes
38, 42
Filing date
05/19/2015
Registration date
03/08/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/12/2026
Last transaction
06/02/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
02/24/2015
First use in commerce
02/24/2015
Drawing code
4
Owner type
16
Owner location
COPPELL, TX, US
Examiner
MICKLEBURGH, LINDA BOHANNON
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CARESIGNAL, LLC
Epharmix, Inc.
Representatives
Tyler J. White Butler Snow LLP
Technical classification
Nice Classes
Class 38Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 38
Provision of short message service (SMS) transmission services; Providing an SMS-based messaging service with condition-specific dialogues for enabling healthcare professionals to communicate with patients or caregivers for determining when to initiate medical interventions
Class 42
Software as a service (SAAS) services featuring software for mobile messaging system through push notificationsresulting in a direct message to the mobile device; Medical research and health care incorporating the use of a messaging system for the exchange of information between each person in that person's family tree network of related personsapplicable in the general field of information and communication systemsespecially the particular fields of medical informatics and medical telematics; Providing a website with non-downloadable SMS-based messaging software with condition-specific dialogues for enabling healthcare professionals to communicate with patients or caregivers for determining when to initiate medical interventions
Publications
History of USPTO decisions and trademark events.
28 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/12/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/12/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/12/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
03/09/2026
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/17/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/08/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/01/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/01/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/01/2021
E815
TEAS SECTION 8 & 15 RECEIVED
03/31/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/08/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/08/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/22/2015
PUBO
PUBLISHED FOR OPPOSITION
12/22/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/02/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/18/2015
ALIE
ASSIGNED TO LIE
11/18/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/03/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/02/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/28/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/28/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/02/2015
GNRT
NON-FINAL ACTION E-MAILED
09/02/2015
CNRT
NON-FINAL ACTION WRITTEN
09/02/2015
DOCK
ASSIGNED TO EXAMINER
08/31/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/28/2015
NWAP
NEW APPLICATION ENTERED
05/22/2015
Continuous trademark protection
Get notified about every new filing that threatens EPHARMIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.